167 related articles for article (PubMed ID: 5764800)
1. [Peripheral hemodynamic criteria and blood flow stimulating vasoactive drugs in healthy persons and in patients with arterial obstruction of the extremities].
Ehringer H
Med Welt; 1969 Jan; 3():148-60. PubMed ID: 5764800
[No Abstract] [Full Text] [Related]
2. [Clinical observations with a new combination of peripheral vasodilating agents].
Dameno G
Minerva Cardioangiol; 1967 Mar; 15(5):357-9. PubMed ID: 5603842
[No Abstract] [Full Text] [Related]
3. [Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs].
Dabizzi RP; Fantini F; Cappelli G; Grandonico F
Minerva Cardioangiol; 1970 May; 18(5):287-90. PubMed ID: 5515012
[No Abstract] [Full Text] [Related]
4. [Report on the clinical testing of Lamuran (I)].
Steinorth G
Med Welt; 1967 Sep; 35():2025-32 contd. PubMed ID: 5595993
[No Abstract] [Full Text] [Related]
5. [Clinical experiences with Rauwolfia alkaloid raubasin (Lamuran) in arterial, venous and lymphatic circulation disorders].
Brembach H
Med Welt; 1970 Feb; 6():240-3. PubMed ID: 5524036
[No Abstract] [Full Text] [Related]
6. [Trial of a new central and peripheral vaso-regulator therapeutic agent: DF 69].
Laveant-Hebrard C; Camus JP
Therapeutique; 1970 Oct; 46(8):805-6. PubMed ID: 4989868
[No Abstract] [Full Text] [Related]
7. [Hemodynamic changes after intravenous administration of ajmaline in cardiopathic patients].
Knippel M; Brusoni B; Cadel A
Boll Soc Ital Cardiol; 1971; 16(1):47-56. PubMed ID: 5104118
[No Abstract] [Full Text] [Related]
8. [Results of clinical trials of raubasin].
Weidinger P
Med Welt; 1970 Mar; 10():403-8. PubMed ID: 4908367
[No Abstract] [Full Text] [Related]
9. [The influence of combined Rauwolfia-saluretic therapy on the hemodynamics of hypertensive patients].
Heimsoth V; Hartmann F; Hundeshagen H
Arch Klin Med; 1966; 212(3):237-50. PubMed ID: 5974124
[No Abstract] [Full Text] [Related]
10. [Pharmacodynamic effect of chelating agents on the peripheral and renal circulation of persons with healthy blood vessels and with vascular diseases].
Hackel F; Graubitz M
Z Gesamte Inn Med; 1969 Nov; 24(21):761-6. PubMed ID: 4983476
[No Abstract] [Full Text] [Related]
11. [Xylocaine--anti-arrhythmic activity, clinical tolerance and hemodynamic repercussions (comparison with ajamline)].
Bernard R; Vainsel H; Lewinson H; Renta C; Cornil A
G Ital Cardiol; 1972; 2(1):159-60. PubMed ID: 5011999
[No Abstract] [Full Text] [Related]
12. [Relationship between blood flow values of the upper and the lower extremities and effects of a vasoactive agent in persons with normal circulation and patients with vascular diseases].
Caesar K
Med Welt; 1971 Apr; 14():559-62. PubMed ID: 5551942
[No Abstract] [Full Text] [Related]
13. [A new Soviet-made hypotensive preparation, rauvakan].
Stupnitskiĭ AA; Ishkov VI
Klin Med (Mosk); 1974 Jul; 52(7):121-5. PubMed ID: 4603303
[No Abstract] [Full Text] [Related]
14. [Rheocencephalographic changes in cerebral vascular diseases in the aged treated with the association of Raubasine and ergot alkaloids].
Pasoli CA; Mansoldo G
Minerva Cardioangiol; 1970 Apr; 18(4):267-71. PubMed ID: 5423416
[No Abstract] [Full Text] [Related]
15. Hemodynamic effects of ethaverine hydrochloride in patients with peripheral vascular disease.
Asby GR; Stein M; Conrad MC; Michie DD
Curr Ther Res Clin Exp; 1974 Oct; 16(10):1096-100. PubMed ID: 4215620
[No Abstract] [Full Text] [Related]
16. [Hemodynamic structure of hypotensive effect in the treatment of elderly and old patients with arterial hypertension].
Tokar' AV
Klin Med (Mosk); 1974 Jul; 52(7):117-21. PubMed ID: 4848858
[No Abstract] [Full Text] [Related]
17. [Effect of raubasine in treatment of peripheral arterious circulation disorders].
Koch G; Eide M
Med Klin; 1972 Nov; 67(46):1519-21. PubMed ID: 4265445
[No Abstract] [Full Text] [Related]
18. [Clinical and experimental study on the effect of magnesium compositum on the blood circulation of extremities and kidney hemodynamics in health subjects and patients with vascular diseases].
Hackel F
Z Gesamte Inn Med; 1970 Jul; 25(14):635-41. PubMed ID: 5516164
[No Abstract] [Full Text] [Related]
19. [On the drug therapy of arterial blood circulation disorders].
Braun W
Med Klin; 1967 Aug; 62(34):1310-2. PubMed ID: 5593010
[No Abstract] [Full Text] [Related]
20. [Collateral dilatation therapy in coronary and peripheral arterial occlusive diseases. Experimental and clinical experiences with 1-benzyl-3-ethyl-6,7-dimethoxyisoquinoline hydrochloride (BEN)].
Nordeck H; Eichler K; Mulch R; Völker D
Munch Med Wochenschr; 1971 Jul; 113(27):1006-11. PubMed ID: 5108693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
